期刊文献+

bcl-2基因在鼻咽癌中的表达 被引量:1

下载PDF
导出
摘要 目的研究bcl2基因在鼻咽癌中的表达及其与预后的关系。方法对84例鼻咽癌和21例非癌样本中bcl2mRNA进行逆转录聚合酶链反应定量分析及单链构象多态性分析。结果①鼻咽癌组bcl2mRNA的水平比非癌组高,差异有显著性(新发组P<0.05,复发组P<0.01);②鼻咽癌复发组bcl2mRNA的水平比新发组高,差异有显著性(P<0.05)。③逆转录聚合酶链反应单链构象多态性分析未发现所检查的基因片段有点突变。结论鼻咽癌中bcl2的表达增高,其过度表达可能是由转录增强所引起,bcl2的高表达提示鼻咽癌预后不良。
出处 《哈尔滨医科大学学报》 CAS 北大核心 2005年第3期231-232,共2页 Journal of Harbin Medical University
  • 相关文献

参考文献7

  • 1Seliger B,Papadileris S,Voge D,et al.Analysis of the p53 and MDM-2 gene in acute myeloid leukemia[J].Eur J Haematol,1996,57(3)∶230-240.
  • 2Shintaku S,Ohdan H,Yamamoto H,et al.Expression of bcl-2 homologue mRNA s in rat liver allograft:apoptosis is associated with upregulation of bax and bcl-xs[J].Transpl Int,1998,11 (Suppl 1)∶s284-288.
  • 3Waston AJ,Merritt AJ,Jones LS,et al.Evidence of reciprocity of bcl-2 and p-53 expression in human colorectal adenomas and carcinomas[J].Br J Cancer,1996,73(8):889-895.
  • 4Harn HJ,Ho LI,Liu CA,et al.Down regulation of bcl-2 by p53 in nasopharyngeal carcinoma and lack of detection of its specific t(14;18) chromos omal translocation in fixed tissues[J].Histopathology,1996,28(4)∶317-323.
  • 5Lu QL,Elia-G,Lucas S,et al.Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma[J].Int J Cancer,1 993,53(1):29-35.
  • 6马薇,韦敏怡.Bcl-2和Bax蛋白在鼻咽癌中的表达及意义[J].广西医科大学学报,2003,20(1):39-41. 被引量:5
  • 7曾亮.鼻咽癌预后相关标记物的研究进展[J].实用肿瘤杂志,2002,17(6):425-428. 被引量:11

二级参考文献29

  • 1[1]Lin JC, Chen KY, Wang WY, et al. Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma:relationship to diatant metastasis and survival [J].J Clin Oncol, 2001,19(10):2607-2615.
  • 2[2]Hsiao JR, Jin YT, Tsai ST. Detection of cell free Epstein-Barr virus DNA in sera from patient with nasopharyngeal carcinoma [J].Cancer,2002,94(3):723-729.
  • 3[3]Lo YM, Chan AT, Chan LY, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulation Epstein-Barr virus DNA [J].Cancer Res, 2000,60(24):6878-6881.
  • 4[4]Ngan RK, Lau WH, Yip TT, et al. Remarkable application of serum EBV EBER-1 in monitoring response of nasopharyngeal cancer patients to salvage chemotherapy [J]. Ann N Y Acad Sci,2001,945(1):73-79.
  • 5[5]Yoshizaki T, Miwa H, Takeshita H, et al. Elavation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma [J]. J Cancer Res Clin Oncol, 2000,126(2):69-73.
  • 6[6]Dardari R, Khyatti M, Benider A, et al. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma [J]. Iht J Cancer, 2000,86(1):71-75.
  • 7[7]Yoshizaki T,Miyamori H,Hasegawa K,et al.Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth [J]. Oncogene,2000,19(14):1764-1771.
  • 8[8]Fukuda M, Ikuta K, Yanagihara K, Tajima M, Kuratsune H, et al. Effect of transforming growth factor-betal on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines [J]. Virology,2001,288(1):109-118.
  • 9[9]Xu J, Menezes J, Prasad U, et al. Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients [J]. Int J Cancer, 1999,84(4):396-399.
  • 10[10]Cheng AJ, Chiu DT, See LC, et al. Poor prognosi in nasopharyngeal cancer patient with low glucose-6phosphate-dehydrogenase activity [J]. Jpn J Cancer Res, 2001,92(5):576-581.

共引文献12

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部